THE FIRST EXPERIENCE WITH INGARON TREATMENT FOR CONJUNCTIVAL MELANOMA
The paper describes the first experience with the Russian drug Ingaron from an interferon-group in the treatment of patients with conjunctival melanoma. The positive result obtained during 5-to-62-month follow-ups allows its therapeutic action to be positively appreciated.
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2015-04-01
|
| Series: | Opuholi Golovy i Šei |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/54 |